23 May 2023>: Original Paper
Safety and Efficacy of 4 mg·kg Sugammadex for Simultaneous Pancreas-Kidney Transplantation Recipients: A Prospective Randomized Trial
Jiancheng Tang 12ABCDEFG , Rongzhi He 2ABCEF , Lei Zhang 3ABD , Shiyuan Xu 1ABCDEFG*DOI: 10.12659/AOT.940211
Ann Transplant 2023; 28:e940211

Figure 3 (A) Tendency of Glu of 2 groups. (B) Tendency of AMS of 2 groups. Plots of MAP, HR, Scr, CCr, Glu, and AMS of patients in both groups S (deep blue) and N (light blue) in each timepoint. Scr and AMS at T2–6 were significantly lower than that at T0–1 (P<0.01), CCr at T2–6 was significantly higher than that at T0–1 (P<0.01). There was no significantly significant difference in the concentration of Scr, CCr, and AMS between the 2 groups at the same timepoint (P>0.05). MAP, HR, and Glu at T1 in group S were higher compared with group N (P<0.05). MAP, mean arterial pressure; HR, heart rate; Scr, serum creatinine; CCr, creatinine clearance rate; AMS, serum amylase and Glu, blood glucose; S, sugammadex; N, neostigmine. T0, the start of surgery; 8 hours (T1), 12 hours (T2), 36 hours (T3), 60 hours (T4), 84 hours (T5), and 108 hours (T6) after the surgery completed. (This figure was made using Microsoft® Excel® 2019MSO (2303 Build 16.0.16227.20202) 64, Microsoft Corporation).